Search

everythinglearnresearchcommunity

for

Search:↓

Research 10 of 1000+

1. Selective Janus kinase 1 inhibition resolves inflammation and restores hair growth offering a viable treatment option for alopecia areata Skin health and disease · 2023 · 4 citations
2. Tofacitinib for the Treatment of Three Immune-mediated Conditions in One Patient: Ulcerative Colitis, Pyoderma Gangrenosum, and Alopecia Areata Inflammatory Bowel Diseases · 2021 · 5 citations
3. Title Choice of treatment for severe forms of alopecia areata (case reports) Vestnik dermatologii i venerologii · 2025
4. 075 Clinical investigation of JAK inhibitor Tofacitinib in scarring alopecias Journal of Investigative Dermatology · 2017 · 1 citations
5. 331 An open label clinical trial of the JAK inhibitor tofacitinib for alopecia areata Journal of Investigative Dermatology · 2017 · 2 citations
6. Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata JCI insight · 2016 · 222 citations
7. Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review 2026
8. Advances in the mechanism and new therapies of alopecia areata International journal of rheumatic diseases · 2023
9. JAK inhibition in the treatment of alopecia areata – a promising new dawn? Expert review of clinical pharmacology · 2019 · 29 citations
10. Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream Pharmaceutics · 2021 · 24 citations

Community

— no results